NIH #U01CA271252
Enrichment for Tumor-derived Cell-free EBV DNA: Towards a Diagnostic Assay for Endemic Burkitt Lymphoma
Active
- Amount
- $300K–$400K
- Period
- 2024-04-01 → 2029-03-31
- PIs
- 2
Rena R. Xian
Full Professor(heuristic)
Cancer Genomics and Diagnostics · Cancer Research
Compare more Cancer Research professors.
h-index16
i10-index24
Publications111
Citations910
Grants
3 total · 2 active
NIH #U01CA284811
Investigating the EBV methylome in PLWH: Discovery and Development of Novel EBV Diagnostics in Plasma and Saliva
Active
- Amount
- $700K–$800K
- Period
- 2023-09-08 → 2028-08-31
- PIs
- 2
NIH #R01CA250069
Hodgkin Lymphoma in PLWH in South Africa: TB, EBV, and Tumor Molecular Markers
- Amount
- $800K–$900K
- Period
- 2020-04-01 → 2025-03-31
- PIs
- 2
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Emergence of Microsatellite Instability in an Oncogene-Driven Non–Small Cell Lung Cancer Harboring a Canonical <i>EGFR</i> Mutation: A Molecular Tumor Board Discussion (JCO Precision Oncology)2026-07-01
- New preprint: EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND T <sub>REG</sub> -DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL2025-11-21
- New NIH award: Enrichment for Tumor-derived Cell-free EBV DNA: Towards a Diagnostic Assay for Endemic Burkitt Lymphoma2024-04-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-29
Data may not be current
Find elsewhere
ORCID: 0000-0001-5532-6524